ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 666596 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 666596; 2) Community: the network communities that were significantly associated with the response to NSC 666596; 3) Molecule: the relationships between components within communities and NSC 666596; 4) MDR: the compounds that were significantly associated with the NSC 666596.

NSC Compound Enrichment Correlation
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0247979034812109 0.39620692
NSC 244404 Null 0.0247979034812109 0.36521187
NSC 258168 2,6-Pyridinedicarbonitrile, 3,4,5-tris(phenylthio)- 0.0247979034812109 0.21096168
NSC 300289 Pinafide 0.0247979034812109 0.23151176
NSC 328410 Camptothecin Derivative 0.0247979034812109 0.2178758
NSC 32951 Acetic acid, (2,4-dihydroxy-2H-pyran-3(6H)-ylidene)-, 3,4-lactone 0.0247979034812109 0.278383
NSC 33570 Null 0.0247979034812109 0.29354197
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0247979034812109 0.1584726
NSC 359239 Antibiotic X-14766A 0.0247979034812109 -0.076166983
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0247979034812109 0.42770339
Total:151  Current:92    [First] [Prev] [Next] [Last]